Radiation Oncology·Los Angeles, CA

UCLA David Geffen School of Medicine/UCLA Medical Center

Signal lift63%83%+20 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
243–271
p10 – p90
Sample N
131
applicants this cycle
This cycle
no tracked aways yet
Match rate
2.3%
3 of 42 applicants
01Cohort funnelthis cycle
N = 131
Applied
131
100.0%
Invited
42
32.1%
Class size
3
2.3%
J-1 visaF-1 visaAdvancedResearch
Your fitUCLA David Geffen School of Medicine/UCLA Medical Center Program

Create a free profile to see your personalized fit

Get started
Contact
AR
Program Director
Ann Caroline Raldow, MD, MPH, BA
Email director
DN
Program Coordinator
D Liane Nash, MHA
Email coordinator
Training sites4 hospitals · Los Angeles
  • 1
    Ronald Reagan UCLA Medical Center
    Los Angeles, CA
    Primary
  • 2
    UCLA David Geffen School of Medicine/UCLA Medical Center
    Los Angeles, CA
    Sponsor
  • 3
    Santa Monica-UCLA Medical Center
    Santa Monica, CA
    Participant
  • 4
    VA Greater Los Angeles Healthcare System
    Los Angeles, CA
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK243271
180205230255280

Level 2 CE data not available

Interview rates
US MD
46%
US DO
0%
US IMG
0%
Non-US IMG
4%
Applicant origin
In-state
100%
Out-of-state
30%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add UCLA David Geffen School of Medicine/UCLA Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.